Arca Biopharma reported 27.65 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Amgen 18.07 1.77 Jun/2026
Biogen 23.23 9.53 Jun/2026
Brainstorm Cell Therapeutics 0.03 5.89 Sep/2025
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Capricor Therapeutics 2.76K 2.76K Dec/2022
Cipla 35.82 12.26 Jun/2026
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 5.45 1.39 Mar/2026
CSL 16.16 9.59 Dec/2025
Daiichi Sankyo 20.14 0.6 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
GlaxoSmithKline 10.63 4.24 Jun/2026
Grifols 11.2 1.08 Dec/2025
Laboratory Of America 20.47 5.04 Jun/2026
Otsuka Holdings 13 1.31 Jun/2026
Pfizer 11.48 2.16 Jun/2026
United Therapeutics 19.15 1.27 Jun/2026